Filing Details
- Accession Number:
- 0001140361-16-069152
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-08 17:23:43
- Reporting Period:
- 2016-06-07
- Filing Date:
- 2016-06-08
- Accepted Time:
- 2016-06-08 17:23:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1416792 | Relypsa Inc | RLYP | Pharmaceutical Preparations (2834) | 260893742 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1528185 | Helen Torley | C/O Relypsa, Inc. 100 Cardinal Way Redwood City CA 94063 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-06-07 | 1,013 | $19.32 | 1,237 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents shares automatically sold pursuant to the applicable Restricted Stock Unit Award Agreement to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units and delivery of shares.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.26 to $19.41, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.